HealthEquity, Inc. (NASDAQ:HQY) Q2 2025 Earnings Conference Call September 3, 2024 4:30 PM ET

Company Participants

Richard Putnam - IR
Jon Kessler - President & CEO
James Lucania - EVP & CFO
Steve Neeleman - Vice Chair and Founder

Conference Call Participants

Anne Samuel - J.P. Morgan
Glen Santangelo - Jefferies
Sean Dodge - RBC Capital Markets
Stan Berenshteyn - Wells Fargo Securities
Allen Lutz - Bank of America
Scott Schoenhaus - KeyBanc
David Larsen - BTIG
Stephanie Davis - Barclays
Mark Marcon - Baird
George Hill - Deutsche Bank

Operator

Good afternoon and welcome to the HealthEquity Second Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded.

I’d now like to turn the conference over to Richard Putnam. Please go ahead.

Richard Putnam

Thank you, Gary. Appreciate it. Hello everyone. Welcome to HealthEquity's Second Quarter of Fiscal Year 2025 Earnings Conference Call. My name is Richard Putnam. I do Investor Relations for HealthEquity. Joining me today is Jon Kessler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the Company; and James Lucania, one-year anniversary, James, Executive Vice President and CFO.

Before I turn the call over to Jon, I have a couple of reminders. First, a press release announcing the financial results for our second quarter of fiscal 2025 was issued after the market closed this afternoon. These financial results include contributions from our wholly-owned subsidiaries and accounts they administer. The press release includes definitions of certain non-GAAP financial measures that we will reference today. You can find on our Investor Relations website a copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures and a recording of this webcast. The website is ir.healthequity.com.

Second, our comments and responses to your questions today reflect management's view as of today, September 3rd, 2024 and they will contain forward-looking statements, as defined by the SEC, including predictions, expectations, estimates, and other information that might be considered forward-looking. There are many important factors relating to our business which could affect the forward-looking statements made today. These forward-looking statements are subject to risks and uncertainties that may cause the actual results to differ materially from statements made here today.

So we caution you against placing undue reliance on these forward-looking statements, and we also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock, as detailed in our latest Annual Report on Form 10-K and subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events.